In search of physiologically based distribution volume estimates for macromolecules

Clinical Pharmacology and Therapeutics

Volumn 92, Issue 4, 2012, Pages 419-421

  Garzone, P D ^a   Atkinson, A J ^b  

^a PFIZER INC   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 9; INSULIN; TRASTUZUMAB EMTANSINE;

BREAST METASTASIS; CATABOLISM; CHEMICAL MODIFICATION; DECONJUGATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; GLOMERULUS FILTRATION; INTERSTITIAL FLUID; MACROMOLECULE; MOLECULAR SIZE; PLASMA VOLUME; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEADY STATE; VASCULAR ENDOTHELIUM;

EID: 84866626729     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.156     Document Type: Review

References (10)

1. Chudasama, V.L. et al. Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer. Clin. Pharmacol. Ther. 92, 520-527 (2012).
2. Wang, W., Wang, E.Q. & Balthasar, J.P. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 84, 548-558 (2008).
3. Berntorp, P. & Björkman, S. The pharmacokinetics of clotting factor therapy. Haemophilia 9, 353-359 (2003).
4. Sedek, G.S., Ruo, T.I., Frederiksen, M.C., Frederiksen, J.W., Shih, S.-R. & Atkinson, A.J., Jr. Splanchnic tissues are a major part of the rapid distribution spaces of inulin, urea and theophylline. J. Pharmacol. Exp. Ther. 251, 1026-1031 (1989).
5. + metastatic breast cancer. Cancer Chemother. Pharmacol. 56, 361-369 (2005).
6. 131-albumin catabolism and distribution in normal young male adults. J. Clin. Invest. 41, 1312-1333 (1962).
7. Björkman, S. & Åhlén, V. Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis. Eur. J. Clin. Pharmacol. 68, 969-977 (2012).
8. 2-urea kinetics in humans. Clin. Pharmacol. Ther. 53, 419-425 (1993).
9. Björkman, S., Carlsson, M. & Berntorp, E. Pharmacokinetics of Factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation. Eur. J. Clin. Pharmacol. 46, 325-332 (1994).
10. Nakashima, E., Benet, L.Z. General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment. J. Pharmacokinet. Biopharm. 16, 475-492 (1988).